louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT03403647: Effect of Vitamin D on Everolimus Trough Concentrations Among Heart Transplanted Patients
Official title: The Effect of Normalizing Vitamin D Concentrations on Everlomius Trough Concentrations
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Vitamin D Deficiency
Lead sponsor: Sheba Medical Center
Sponsor class: OTHER_GOV
First posted: 2018-01-18
Enrollment: 11
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Vitamin D is part of the regular treatment regimen among patients after heart transplantation. Due to potential drug-drug interaction between vitamin D and everolmus, these patients are in increased risk for increased everolimus metabolism, potentially leading to under- immunosupression.

Detailed description: post heart transplantation patients treated with everolimus will be screened for vitamin D levels. Patients defined as deficient will be treated with vitamin D with close and intensive monitoring everolimus levels, adjusting oral daily dose to maintain therapeutic levels.

Eligibility criteria: Inclusion Criteria:

Heart transplanted patients treated with everolimus

Exclusion Criteria:

-

Primary outcomes:
measure: Oral daily everolimus dose change
timeFrame: 8 weeks
Secondary outcomes:
Other outcomes:
Locations:
city: Ramat Gan
country: Israel
facility: Sheba Medical Center
Study officials:
References:
Clinical trial NCT01722747: Bihar School Teachers Study
Official title: Promoting Tobacco Control Among Teachers in India
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Tobacco Use Cessation
Lead sponsor: Harvard School of Public Health (HSPH)
Sponsor class: OTHER
Collaborators: name: Healis-Sekhsaria Institute for Public Health
name: Carelon Research
name: University of Minnesota
name: School of Preventive Oncology
First posted: 2012-11-07
Enrollment: 945
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: BRIEF SUMMARY: This study, which is closed to enrollment, is testing the efficacy of a tobacco-control intervention geared towards school teachers in Bihar, India. This cluster randomized trial aims to promote tobacco use cessation among teachers and increase tobacco policy adoption in 72 Bihar schools. Teachers are the focus of the study because as role models for youth and key opinion leaders related to community norms, they represent an important group for tobacco control. Teachers in Bihar also have reported high rates of tobacco use. According to the Global School Personnel Survey conducted in 2006, 39% of teachers in the eastern region of India (which includes Bihar) use some form of tobacco, compared to the national average of 29%. This study aims to reduce these numbers through discussion groups with teachers, individual cessation counseling, educational materials, and a tobacco policy workgroup in each intervention school. This study is a collaboration between US researchers and researchers at the Healis-Sekhsaria Institute for Public Health, Mumbai India.


Eligibility criteria: Inclusion Criteria:

* Government schools including grades 8-10 from within 10 school districts

Exclusion Criteria:

* Schools with fewer than 8 teachers
* Schools located in flood zones

Primary outcomes:
measure: 6-month abstinence from tobacco
timeFrame: assessed 9-months post-intervention
Secondary outcomes:
measure: Adoption of a school tobacco policy
timeFrame: 9-month post-intervention
measure: short-term tobacco use cessation
timeFrame: Average of 3 weeks post-intervention
Other outcomes:
Locations:
city: Patna
country: India
facility: School of Preventive Oncology
state: Bihar
Study officials:
affiliation: Harvard School of Public Health (HSPH)
name: Glorian C. Sorensen, PhD, MPH
role: PRINCIPAL_INVESTIGATOR
References:
citation: Nagler EM, Pednekar MS, Viswanath K, Sinha DN, Aghi MB, Pischke CR, Ebbeling CB, Lando HA, Gupta PC, Sorensen GC. Designing in the social context: using the social contextual model of health behavior change to develop a tobacco control intervention for teachers in India. Health Educ Res. 2013 Feb;28(1):113-29. doi: 10.1093/her/cys060. Epub 2012 Jun 4.
citation: Pischke CR, Galarce EM, Nagler E, Aghi M, Sorensen G, Gupta PC, Pednekar MS, Sinha DN, Viswanath K. Message formats and their influence on perceived risks of tobacco use: a pilot formative research project in India. Health Educ Res. 2013 Apr;28(2):326-38. doi: 10.1093/her/cys112. Epub 2012 Dec 6.
Clinical trial NCT01152047: The Effect of Oxytocin on Gastric Emptying
Official title: The Effect of Oxytocin on Satiety in Patients With Dyspepsia
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Dyspepsia
Lack of Satiety
Keywords: oxytocin
satiety
dyspepsia
Lead sponsor: Skane University Hospital
Sponsor class: OTHER
First posted: 2010-06-29
Enrollment: 14
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The investigators have seen that oxytocin lowers satiety in healthy subjects. Patients with dyspepsia suffers from decreased accommodation and increased satiety postprandially. The investigators now want to examine whether oxytocin may diminish symptoms in these patients.

Detailed description: Patients will come twice for a slow satiety drinking test. Once they will get saline infusion and once oxytocin 40 mU/min. At the same time they register satiety on a VAS scale.

Eligibility criteria: Inclusion Criteria:

* Dyspepsia

Exclusion Criteria:

* Age \> 65 years
* Cardiac disease

Primary outcomes:
measure: Satiety
timeFrame: 2 h
Secondary outcomes:
Other outcomes:
measure: To see if oxytocin lowers satiety
timeFrame: 2h
Locations:
city: Malmö
country: Sweden
facility: Skåne University Hospital
Study officials:
affiliation: Divsion of Internal Medicine
name: Bodil Ohlsson, professor
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT05261347: Effect of Mulligan Movement Mobilization Technique on Elbow Joint Proprioception
Official title: Effect of Mulligan Movement Mobilization Technique on Elbow Joint Proprioception
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Healthy
Lead sponsor: Dokuz Eylul University
Sponsor class: OTHER
First posted: 2022-03-02
Enrollment: 48
Sex: ALL
Minimum age (years): 18
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Investigating The Effects of Mulligan Movement Mobilization Technique on Elbow Joint Proprioception

Detailed description: Investigating The Effects of Mulligan Movement Mobilization Technique on Elbow Joint Proprioception by joint position sense assessment

Eligibility criteria: Inclusion Criteria:

* 18-85 years

Exclusion Criteria:

* having any elbow condition
* having any neurological condition

Primary outcomes:
measure: elbow proprioception assessment by evaluating joint position sense
timeFrame: 35 minutes
Secondary outcomes:
Other outcomes:
Locations:
city: Balçova
country: Turkey
facility: Physical Therapy and Rehabilitation School
state: İzmir
Study officials:
affiliation: Dokuz Eylul University
name: kevser sevik
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT03915145: The Effects of Kinesio Taping in Women With Primary Dysmenorrhea
Official title: Assistant Professor, Physioterapist, PhD
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Primary Dysmenorrhea
Lead sponsor: Ataturk Training and Research Hospital
Sponsor class: OTHER
First posted: 2019-04-16
Enrollment: 60
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 35
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: FACTORIAL
Primary purpose: TREATMENT

Brief summary: The aim of our study was to investigate the effects of kinesio taping in women with primary dysmenorrhea.


Eligibility criteria: Inclusion Criteria:

* 18 to 35 years of age,
* having Primary Dysmenorrhea
* being volunteer women

Exclusion Criteria:

* having give birth,
* having a serious psychiatric disorder
* having used oral contraceptive or depression drug in the last 6 month
* having secondary dysmenorrhea
* having irregular menstrual cycle
* having allergy to taping

Primary outcomes:
measure: The severity of menstrual pain assessed with Visual Analog Scale
timeFrame: An average of 2 weeks
Secondary outcomes:
measure: The complaints related to menstruation will be evaluated by a form prepared by the researchers
timeFrame: An average of 2 weeks
measure: The level of anxiety will be evaluated with The Spielberger State Trait Anxiety Inventory
timeFrame: An average of 2 weeks
Other outcomes:
Locations:
city: Ankara
country: Turkey
facility: Ankara Yildirim Beyazit University
Study officials:
affiliation: Ankara Yildirim Beyazıt University
name: Seyda TOPRAK CELENAY
role: PRINCIPAL_INVESTIGATOR
affiliation: Gümüşhane Universıty
name: Basak Kavalci
role: STUDY_CHAIR
affiliation: Ankara Yildirim Beyazıt University
name: Aysenur Karakus
role: STUDY_CHAIR
References:
Clinical trial NCT04985045: Menstrual Health and Genital Hygiene Status in Cerebral Palsy
Official title: Determination of Menstrual Health and Genital Hygiene Status in Women With Cerebral Palsy
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Menstrual Problem
Cerebral Palsy
Women's Health
Lead sponsor: Gulhane School of Medicine
Sponsor class: OTHER
First posted: 2021-08-02
Enrollment: 128
Sex: FEMALE
Minimum age (years): 10
Maximum age (years): 30
Standard ages: CHILD
ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Women with menstrual cycle

Brief summary: There is little information about the menstrual health and genital hygiene behaviors of young women with CP. The most important reason for this is that women with CP did not meet the inclusion criteria and were excluded from the study. This may lead to a knowledge gap that limits the design of approaches that can help women and families with CP. Therefore, this study was planned to determine menstrual health and genital hygiene behaviors in women with CP.


Eligibility criteria: Inclusion Criteria:

for women with cerebral palsy (CP)

1. Participating in the research voluntarily,
2. Being diagnosed with CP
3. To be GMFCS level I-II-II
4. to be 10-30 years old,
5. Being able to read and write Turkish,
6. Not having any mental problems that prevent cooperation and understanding,
7. Being a woman
8. To have menstruated at least once.

For healthy women

1. Participating in the research voluntarily,
2. to be 10-30 years old,
3. Being able to read and write Turkish,
4. Not having any mental problems that prevent cooperation and understanding,
5. Being a woman
6. To have menstruated at least once.

Exclusion Criteria:

1. Having a history of pregnancy
2. Having an acute genital infection
3. To have undergone gynecological surgery.

Primary outcomes:
measure: Menstrual Pain
timeFrame: A month
measure: Menstruation-related symptoms
timeFrame: A month
measure: Genital Hygiene status
timeFrame: A month
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
References:
Clinical trial NCT06721845: Non-Cirrhotic Hyperammonemia Versus Hyperlactatemia in Septic Patients and Impact of Treatment
Official title: Non-Cirrhotic Hyperammonemia Versus Hyperlactatemia in Septic Patients and Impact of Treatment
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Sepsis
Keywords: sepsis
hyperammonemia
hyperlactemia
prediction
Lead sponsor: Menoufia University
Sponsor class: OTHER
First posted: 2024-12-06
Enrollment: 60
Sex: ALL
Minimum age (years): 19
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: patient with sepsis or septic shock

Brief summary: Objectives: This study aims to determine the validity of hyperammonemia in predicting true sepsis compared to hyperlactemia in critically ill septic patients.

Background: Sepsis is associated with amino acid flux towards the liver, which increases the ammonia load. The combination of decreased clearance and increased load is thought to be the major cause of increased ammonia in sepsis.

Methodology: 60 septic patients were classified into 2 equal groups, Group I: Septic patients with positive microbial cultures. Group II: septic patients with negative cultures enrolled to obtain serum ammonia and lactic acid levels on admission and every six hours for three days. The primary outcome was to detect ammonia specificity and sensitivity in predicting sepsis in comparison to lactate. The secondary outcomes were need for mechanical ventilation, mortality, and length of stay (LHS) within the intensive care unit.

Detailed description: Objectives: The study compares between non-cirrhotic hyperammonemia and hyperlactemia in predicting sepsis in critically ill septic patients.

The septic patients were classified into 2 equal groups, Group I: Septic patients with positive microbial cultures. Group II: septic patients with negative cultures enrolled to obtain serum ammonia and lactic acid levels on admission and every six hours for three days, to detect ammonia specificity and sensitivity in predicting sepsis in comparison to lactate. also, need for mechanical ventilation, mortality, and length of stay (LHS) within the intensive care unit were reported.

Eligibility criteria: Inclusion Criteria:

* adult patients aged 19-75 years old
* both sexes with severe sepsis and septic shock
* within the first 48 hours of ICU admission

Exclusion Criteria:

* Hepatic patients (cirrhotic, hepatitis),
* Renal failure, Ureterosigmoidostomy,
* Malignancy or on Chemotherapy,
* Pregnancy,
* Parenteral nutrition,
* Autoimmune diseases or Immunosuppressive illness, and
* Trauma

Primary outcomes:
measure: Serum ammonia specificity and sensitivity in predicting sepsis in comparison to lactate
timeFrame: up to three days.
Secondary outcomes:
Other outcomes:
Locations:
city: Shibin Elkoom
country: Egypt
facility: Menoufia Faculty of Medicine
state: Menoufia
Study officials:
References:
Clinical trial NCT03495245: Identification of Potential Biomarkers for Pain
Official title: Development of a Serum Biomarker-Based Approach to Monitor Opioid Adherence and Minimize Substance Misuse in Chronic Pain Management
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Fibromyalgia
Keywords: pain
opioid
fibromyalgia
Lead sponsor: Rowan University
Sponsor class: OTHER
Collaborators: name: American Osteopathic Association
First posted: 2018-04-11
Enrollment: 200
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_CONTROL
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: Patients that are seen at the NeuroMusculoskeletal Institute at Rowan University School of Osteopathic Medicine.

Brief summary: The study investigates the potential of using serum biomarkers to assess pain in fibromyalgia patients.

Detailed description: At the heart of the opioid epidemic is the lack of an objective measure of pain, which will help evaluate the validity of the patients' perception that the current dosage of opioid is sufficient of insufficient to alleviate pain. This study will test the quantifiable proteins such as S100B and BDNF will serve as objective measures (biomarkers) of pain.

Fibromyalgia patients will be recruited into two groups-- one that uses opioids and the other that does not. Blood will be collected every 6 months for two years. The serum will be used to assay for levels of S100B and BDNF, The pressure-pain threshold (PPT) data, as part of standard of care, will also be collected. Correlation will the be assessed.

Eligibility criteria: Inclusion Criteria:

* Diagnosed with Fibromyalgia

Exclusion Criteria:

* Evidence of a history of substance abuse, neurological or oncologic disease, ischemic heart disease, kidney or hepatic insufficiency.

Primary outcomes:
measure: Serum protein levels as a marker for pain
timeFrame: 2-4 years
Secondary outcomes:
measure: Determine if correlation may be established between impact of fibromyalgia and opioid doses
timeFrame: 2-4 years
measure: Determine if correlation may be established between sleep index and opioid doses
timeFrame: 2-4 years
Other outcomes:
Locations:
city: Stratford
country: United States
facility: Rowan University School of Osteopathic Medicine
state: New Jersey
Study officials:
affiliation: Rowan University School of Osteopathic Medicine
name: Venkateswar Venkataraman, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT01497145: A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome
Official title: A Phase 2, Randomized, Open-Label, Parallel, Comparative, Dose-Response Study to Evaluate the Efficacy and Safety of KRN321 in Adult Subjects With Low- or Intermediate-1-Risk Myelodysplastic Syndrome
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE2
Conditions: MDS
Lead sponsor: Kyowa Kirin Co., Ltd.
Sponsor class: INDUSTRY
First posted: 2011-12-22
Enrollment: 45
Sex: ALL
Minimum age (years): 20
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This is a multicenter, Randomized, Open-Label, Parallel, Comparative, Dose-Response Study to Evaluate the Efficacy and Safety study of KRN321 of subcutaneous injection in Adult Subjects with Low- or Intermediate-1-Risk Myelodysplastic Syndrome.


Eligibility criteria: Inclusion Criteria:

* IPSS low- or intermediate-1-risk MDS diagnosed at enrollment
* Serum EPO concentration ≤ 500 mIU/mL
* Hemoglobin concentration ≤ 9.0 g/dL at the screening examinations

Exclusion Criteria:

* Previous bone marrow or hematopoietic stem cell transplantation
* History of pure red cell aplasia
* Cardiac conditions including angina pectoris, congestive heart failure, uncontrolled arrhythmia and hypertension
* Those who have increased risk of thrombosis during the study
* Uncontrolled diabetes mellitus
* Concurrent active infection or chronic inflammatory disease
* Other causes of anemia
* Previous or concurrent active malignancies other than MDS

Primary outcomes:
measure: The proportion of subjects achieving a erythroid response
measure: Adverse Events as a Measure of Safety
Secondary outcomes:
Other outcomes:
Locations:
city: Saitama
country: Japan
city: Seoul
country: Korea, Republic of
Study officials:
References:
Clinical trial NCT00758745: Randomized Contralateral Clinical Trial With Single-piece (SN60WF) vs. Three Piece (MA60AC) AcrySof Intraocular Lenses (IOLs) on Development of Posterior Chamber Opacification (PCO).
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cataract
Keywords: Cataract
Patients
bilateral
age related
undergoing
phacoemulsification
Lead sponsor: Alcon Research
Sponsor class: INDUSTRY
First posted: 2008-09-25
Enrollment: 81
Sex: ALL
Minimum age (years): 50
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Randomized contralateral clinical trial with single piece (Model SN60WF) vs. three piece (Model MA60AC) AcrySof Intraocular Lenses (IOLs) on development of Posterior Chamber Opacifiation (PCO).


Eligibility criteria: Inclusion Criteria:

* Age \> 50 years
* Clear cornea
* Pupil mydriasis ≥ 7mm
* In the bag Intraocular Lens (IOL)

Exclusion Criteria:

* Ocular pathology - uveitis, glaucoma, pseudoexfoliation syndrome (PEX), high myopia
* Previously operated eye
* Proliferative diabetic retinopathy
* Surgical complications - incomplete rhexis, post capsular rupture (PCR), zonular dialysis

Primary outcomes:
measure: Posterior Capsule Opacification (PCO)
timeFrame: Up to 3 years
Secondary outcomes:
Other outcomes:
Locations:
city: Fort Worth
country: United States
facility: Contact Alcon Call Center for Study Locations
state: Texas
Study officials:
References:
Clinical trial NCT01017445: Stick Versus Quadricep Exercise for Knee Osteoarthritis
Official title: Boonme Stick Exercise vs. Quadriceps Strengthening Exercise in Knee Osteoarthritis : A Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE3
Conditions: Knee Osteoarthritis
Keywords: osteoarthritis, exercise
Lead sponsor: Prince of Songkla University
Sponsor class: OTHER
First posted: 2009-11-20
Enrollment: 100
Sex: ALL
Minimum age (years): 50
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This study aims to compare the efficacy between Boonme stick exercise and quadriceps strengthening exercise in knee osteoarthritis.Patients diagnosed as knee osteoarthritis using Altman criteria will be randomized into 2 groups using simple random technique. Patients will be instructed and trained for both quadriceps or Boonme stick exercise by one-trained physical therapist. All patients will be treated with behavioral modification, NSAIDs and analgesic drugs and regularly follow-up . Assessment included visual analogue scale, exercise compliance, WOMAC and patient satisfaction were done by an assessor in a blinded fashion.


Eligibility criteria: Inclusion Criteria:

* knee osteoarthritis using Altman criteria

Exclusion Criteria:

* problem of communication ability

Primary outcomes:
measure: vas score
timeFrame: 1,2 years
Secondary outcomes:
measure: WOMAC
timeFrame: 1,2 yrs
measure: number of analgesic used
timeFrame: 1,2 years
Other outcomes:
Locations:
city: Hat Yai
country: Thailand
facility: Prince of Songkla University
state: Songkhla
Study officials:
affiliation: Faculty of Medicine, Prince of Songkla University
name: Boonsin Tangtrakulwanich, MD.,Ph.D
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT03323645: Prosthetics Registry and Outcomes in Urology at Duke
Official title: Prosthetics Registry and Outcomes in Urology at Duke
Study type: OBSERVATIONAL
Overall status: TERMINATED
Conditions: Penile Implantation
Keywords: prostate cancer
erectile dysfunction
penile prosthesis
Lead sponsor: Duke University
Sponsor class: OTHER
First posted: 2017-10-27
Enrollment: 190
Sex: MALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: OTHER
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Men with end-stage erectile dysfunction.

Brief summary: To establish the Prosthetics Registry and Outcomes in Urology at Duke (PROUD) which will serve as a retro- and prospective data repository that our team will use to optimize patient satisfaction, lower cost and reduce morbidity associated with penile prosthesis implantation. The study team will collect retrospective data from subjects at Duke University and Duke Raleigh Hospitals who have undergone genitourinary prosthesis implantation from January 1, 1996 onward. Prospective data will only be collected from patients seeking care with Dr. Lentz in Duke Raleigh.


Eligibility criteria: Inclusion Criteria:

* Male
* Adult (18 years of age or older)
* Inflatable or semi-rigid penile prosthesis placed

Exclusion Criteria:

- Inability to provide informed consent

Primary outcomes:
measure: Development of data repository to capture longitudinal outcomes and satisfaction for subjects who receive penile prostheses.
timeFrame: up to 5 years
Secondary outcomes:
Other outcomes:
Locations:
city: Raleigh
country: United States
facility: Duke Raleigh
state: North Carolina
Study officials:
affiliation: Duke University
name: Aaron C Lentz, MD
role: PRINCIPAL_INVESTIGATOR
References: